Abstract 118P
Background
Gastric cancer (GC) is a fourth leading cancer in Nepal and third most common cause for cancer-related mortality. This case-control study was carried out to find an association of behavioral and dietary factors in gastric cancer development among adult Nepali populations.
Methods
This study was conducted from Jan 2021 to Dec 2021 at Patan Academy of Health Sciences(PAHS), Lalitpur Nepal. In total, 89 patients with GC and 89 patients not having GC were studied as controls. Data were collected via face to face interview using a standard structured questionnaire, posing question about socio-demographic, behavioral and dietary habits, and clinical factors. Logistic regression method was used to calculate the odds ratio.
Results
The most common age group for both case and control was 55 to 65 years. The results showed that regular intake of red meat, duration of smoking, smokeless tobacco, fast food and fatty food, and family history of any type of cancer were directly associated with the risk of stomach cancer. On the contrary intake of chicken and vegetables, tea and coffee, regular walking and sports habit have inverse association with stomach cancer. Adjusted odds ratio shows, regular consumption of red meat have 2 times more risk (OR=2.0) of developing stomach cancer compare to irregular meat consumption. Moreover, person with history of H. pylori infection found 53% (OR=7.263; 95% CI; 3.614-14.597) more likely to develop stomach cancer.
Conclusions
Nepali studies on this topic are limited and more research is required to understand the etiology, need for development of suitable screening test, to demarcate high-risk population and to develop and evaluate the effect of primary prevention programs.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
88P - Sintilimab plus anlotinib as second-line therapy for metastatic or recurrent gallbladder carcinoma (GBC): A single-arm, phase II study
Presenter: Qingbao Cheng
Session: Poster viewing 02
89P - Radiotherapy followed by camrelizumab for unresectable biliary tract cancer: A phase II clinical trial
Presenter: Zhenwei Peng
Session: Poster viewing 02
90P - Feasibility of using tumor-informed circulating tumor DNA (ctDNA)-based testing for patients with anal squamous cell carcinoma
Presenter: Georges Azzi
Session: Poster viewing 02
92P - Safety of liver resection following atezolizumab plus bevacizumab treatment in hepatocellular carcinoma (HCC) patients with macrovascular invasion: A pre-specified analysis of the TALENTop study
Presenter: Huichuan Sun
Session: Poster viewing 02
93P - Outcomes by disease status in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase III TOPAZ-1 study
Presenter: Takuji Okusaka
Session: Poster viewing 02
94P - The treatment burden of neoadjuvant carboplatin/paclitaxel versus 5-fluorouracil/cisplatin in combination with radiotherapy for patients with esophageal cancer
Presenter: Chun-Ling Chi
Session: Poster viewing 02
95P - Additional survival follow-up of TACTICS-L: Transcatheter arterial chemoembolization therapy (TACE) in combination strategy with lenvatinib in (LEN) patients with unresectable hepatocellular carcinoma in Japan
Presenter: Yoshitaka Inaba
Session: Poster viewing 02
96P - Preoperative chemotherapy flot vs dox in patients of locally advanced gastric adenocarcinoma
Presenter: POORNIMA DEVI UTHAYAKUMAR
Session: Poster viewing 02
97P - BEAR study: A single-arm, phase II trial of BI-754091 and afatinib for refractory esophageal squamous cell carcinoma
Presenter: Nai-Jung Chiang
Session: Poster viewing 02